Morgan Stanley »

Connect Biopharma Hldgs shares owned by Morgan Stanley

Quarter-by-quarter ownership of Connect Biopharma Hldgs (CNTB) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Connect Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Connect Biopharma Hldgs held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Connect Biopharma Hldgs by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.4k 3.6k 2.62
2025-12-31 $6.2k 2.2k 2.82
2025-09-30 $151 100 1.51

More positions owned by Morgan Stanley

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)

View all positions for Morgan Stanley

Top funds holding Connect Biopharma Hldgs

Ikarian Capital
Boothbay Fund Management
683 Capital Management
Perceptive Advisors
ADAR1 Capital Management
Richmond Brothers
Millennium Management
BML Capital Management
Knott David M Jr
Susquehanna International
Stonepine Capital Management
Propel Bio Management
Diadema Partners
Burkehill Global Management
Renaissance Technologies

View all funds holding Connect Biopharma Hldgs